Invivyd, Inc. (IVVD)
0.9976
+0.03
(+3.43%)
USD |
NASDAQ |
Aug 31, 10:05
Invivyd Shareholders Equity (Quarterly) : 181.08M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 181.08M |
| March 31, 2026 | 203.05M |
| December 31, 2025 | 241.54M |
| September 30, 2025 | 93.07M |
| June 30, 2025 | 42.79M |
| March 31, 2025 | 54.15M |
| December 31, 2024 | 67.54M |
| September 30, 2024 | 83.16M |
| June 30, 2024 | 140.64M |
| March 31, 2024 | 178.50M |
| December 31, 2023 | 177.47M |
| September 30, 2023 | 246.50M |
| Date | Value |
|---|---|
| June 30, 2023 | 281.56M |
| March 31, 2023 | 326.75M |
| December 31, 2022 | 355.97M |
| September 30, 2022 | 377.44M |
| June 30, 2022 | 414.84M |
| March 31, 2022 | 459.39M |
| December 31, 2021 | 558.02M |
| September 30, 2021 | 633.21M |
| June 30, 2021 | 360.09M |
| March 31, 2021 | 66.19M |
| December 31, 2020 | 104.30M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
| Imunon, Inc. | 4.189M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 218.88M |
| Total Liabilities (Quarterly) | 37.80M |
| Debt to Equity Ratio | 0.0463 |
| Current Ratio | 5.869 |
| Net Debt Paydown Yield | -0.58% |